Delivery Order SPE2DB22D1103-SPE2DB24FTQK6
Award Date
8/20/24
Potential Completion Date
8/21/24
Potential Value
$8.4K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,988.66, is for the provision of PULMOZYME 1 MG/ML AMPUL 2.5ML, a medical product. The contract has an ultimate completion date of December 31, 2024 and is a firm fixed-price delivery order. Amerisourcebergen Drug Corp is a for-profit organization registered in the System for Award...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of PULMOZYME 1 MG/ML AMPUL 2.5ML, a pharmaceutical product, with a ceiling value of $15,622.39 and a completion date of March 5, 2024. The contract is a firm fixed-price, open competition award with no set-aside designation. Amerisourcebergen holds a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $8,787.04 firm fixed price contract is for the delivery of PULMOZYME 1 MG/ML AMPUL 2.5ML, a medical product, with a completion date of March 14, 2025. The contract is not designated as a set-aside. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...
This is a Delivery Order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office division. The contract is for the supply of PULMOZYME 1 MG/ML AMPUL 2.5ML, a pharmaceutical product, with a ceiling value of $2,410.99 and an ultimate completion date of September 5, 2024. The contract is a Firm Fixed Price arrangement and does not utilize any set-aside designations. Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to the...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of PULMOZYME 1 MG/ML AMPUL 2.5ML, a pharmaceutical product, with a ceiling value of $15,836.43 and a performance period through May 28, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of PULMOZYME 1 MG/ML AMPUL 2.5ML, a pharmaceutical product, with a ceiling value of $5,167.20. The contract is a firm fixed-price delivery order, with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is the prime contractor, and the contract has...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $30,882.65, is for the procurement of PULMOZYME 1 MG/ML AMPUL 2.5ML, a medical product used in healthcare. The contract is a firm fixed-price delivery order, with a period of performance through January 23, 2024. The contract was not set aside for any specific business...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract, valued at $14,356.71, is for the supply of the pharmaceutical product Pulmozyme 1 mg/ml ampules (2.5 ml). The contract is a firm fixed-price, delivery order with a period of performance through June 26, 2024. Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is the prime contractor. This award is part of a larger Indefinite...
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,154.31 firm fixed-price contract is for the procurement of PULMOZYME 1 MG/ML AMPUL 2.5ML, a medication used in the treatment of cystic fibrosis. The contract has an ultimate completion date of January 3, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC)...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,568,295,500 units of PULMOZYME 1 MG/ML AMPUL 2.5ML, a pharmaceutical product. The contract has a ceiling value of $11,195.24 and is structured as a Firm Fixed Price Delivery Order. It does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a...